Concepedia

Birte Möhlendick

BM

19

Publications

896

Citations

17

H-Index

2013

Active since

Affiliations

Heinrich Heine University Düsseldorf(Current)

Düsseldorf University Hospital

University of Duisburg-Essen

Fraunhofer Institute for Toxicology and Experimental Medicine

University of Cologne

Birte Möhlendick is an author at Heinrich Heine University Düsseldorf specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2013–2024

19

Publications

19

ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

Birte Möhlendick, Kristina Schönfelder, Katharina Breuckmann et al. · Pharmacogenetics and Genomics · 2021 · 132 citations · Full text

GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine

Ieva Čiučiulkaitė, Birte Möhlendick, Laura Thümmler et al. · Frontiers in Genetics · 2022 · 132 citations · Full text

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations

Susanne Lorenz, Tale Barøy, Jinchang Sun et al. · Oncotarget · 2015 · 85 citations · Full text

Genomic High-Resolution Profiling of Single CKpos/CD45neg Flow-Sorting Purified Circulating Tumor Cells from Patients with Metastatic Breast Cancer

Rui P. Neves, Katharina Raba, Oliver Schmidt et al. · Clinical Chemistry · 2014 · 77 citations

Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study

Kristina Schönfelder, Katharina Breuckmann, Carina Elsner et al. · Frontiers in Genetics · 2021 · 75 citations · Full text

Rows per page

1–5 of 19